Oral agents for ovulation induction - Clomiphene citrate versus aromatase inhibitors

Human Fertility

Volumn 11, Issue 1, 2008, Pages 17-22

  Homburg, Roy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aromatase inhibitors; Clomiphene citrate; Ovulation induction; Polycystic ovary syndrome (PCOS)

Indexed keywords

ANASTROZOLE; ANDROGEN; ANDROSTENEDIONE; AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; DEXAMETHASONE; ESTROGEN; ESTROGEN RECEPTOR; FOLLITROPIN; GLUCOCORTICOID; GONADORELIN; LETROZOLE; METFORMIN; TESTOSTERONE;

ABORTION; BEDTIME DOSAGE; BREAST CANCER; CLINICAL TRIAL; DRUG COST; DRUG DOSE INCREASE; DRUG HALF LIFE; DRUG RECEPTOR BINDING; ENDOMETRIUM; ESTROGEN SYNTHESIS; HORMONE INHIBITION; HUMAN; INCREASED APPETITE; INFERTILITY THERAPY; LIVE BIRTH; LOW DRUG DOSE; MONOTHERAPY; MULTIPLE PREGNANCY; NEGATIVE FEEDBACK; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PROTEIN SYNTHESIS INHIBITION; REVIEW; SIDE EFFECT; TERATOGENICITY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WORLD HEALTH ORGANIZATION;

ABNORMALITIES, DRUG-INDUCED; AROMATASE INHIBITORS; CLOMIPHENE; FEMALE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY, MULTIPLE; TREATMENT FAILURE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 40549140756     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.1080/14647270701689670     Document Type: Review

References (40)

1. Adashi, E. Y., Rock, J. A., Sapp, K. C., Martin, E. J., Wentz, A. C. and Jones, G. S. (1979) Gestational outcome of clomiphene-related conceptions. Fertility & Sterility, 31, pp. 620-626.
2. Agarwal, S. K. and Buyalos, R. P. (1995) Corpus luteum function and pregnancy rates with clomiphene citrate therapy: Comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation. Human Reproduction, 10, pp. 328-331.
3. Ahlgren, M., Kallen, B. and Rannevik, G. (1976) Outcome of pregnancy after clomiphene therapy. Acta Obstetricia et Gynecologica Scandinavica, 55, pp. 371-375.
4. Al-Omari, W. R., Sulaiman, W. R. and Al-Hadithi, N. (2004) Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. International Journal of Gynaecology & Obstetrics, 85, pp. 289-291.
5. Atay, V., Cam, C., Muhcu, M., Cam, M. and Karateke, A. (2006) Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. Journal of International Medical Research, 34, pp. 73-76.
6. Badawy, A., Aal, I. Abdel and Abulatta, M. (2007) Clomiphene or letrozole for ovulation induction in women with polycystic ovary syndrome: A prospective randomized trial. Fertility & Sterility Jun 18
7. Bayar, U., Basaran, M., Kiran, S., Coskun, A. and Gezer, S. (2006) Use of an aromatase inhibitor in patients with polycystic ovary syndrome: A prospective randomized trial. Fertility & Sterility, 86, pp. 1447-1451.
8. Biljan, M. M., Tan, S. L. and Tulandi, T. (2002) Prospective randomized trial comparing the effects of 2.5 and 5.0 mg of letrozole (LE) on follicular development, endometrial thickness and pregnancy rates in patients undergoing superovulation. Fertility & Sterility, 78, p. S55.
9. Correy, J. F., Marsden, D. E. and Schokman, F. C. (1982) The outcome of pregnancy resulting from clomiphene-induced ovulation. Australian & New Zealand Journal of Obstetrics & Gynaecology, 22, pp. 18-21.
10. Daly, D. C., Walters, C. A., Soto-Albors, C. E., Tohan, N. and Riddick, D. H. (1984) A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertility & Sterility, 41, pp. 844-848.
11. de Ziegler, D. (2003) The dawning of the non-cancer uses of aromatase inhibitors in gynaecology. Human Reproduction, 18, pp. 1598-1602.
12. Dickey, R. P., Taylor, S. N., Curole, D. N., Rye, P. H. and Pyrzak, R. (1996) Incidence of spontaneous abortion in clomiphene pregnancies. Human Reproduction, 11, pp. 2623-2628.
13. Dickey, R. P., Taylor, S. N., Curole, D. N., Rye, P. H., Lu, P. Y. and Pyrzak, R. (1997) Relationship of clomiphene dose and patient weight to successful treatment. Human Reproduction, 12, pp. 449-453.
14. Eijkemans, M. J., Habbema, J. D. and Fauser, B. C. (2003) Characteristics of the best prognostic evidence: An example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Seminars in Reproductive Medicine, 21, pp. 39-47.
15. Elnashar, A., Fouad, H., Eldosoky, M. and Saeid, N. (2006) Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle stimulating hormone ratio. Fertility & Sterility, 85, pp. 511-513.
16. Garcia, J., Jones, G. S. and Wentz, A. C. (1977) The use of clomiphene citrate. Fertility & Sterility, 28, pp. 707-717.
17. Greenblatt, R. B., Barfield, W. E., Jungck, E. C. and Ray, A. W. (1961) Induction of ovulation with MRL/41. Preliminary report. Journal of the American Medical Association, 178, pp. 101-104.
18. Gysler, M., March, C. M., Mishell Jr., D. R. and Bailey, E. J. (1982) A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertility & Sterility, 37, pp. 161-167.
19. Hammond, M. G. (1984) Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertility & Sterility, 42, pp. 499-509.
20. Homburg, R. and Insler, V. (2002) Ovulation induction in perspective. Human Reproduction Update, 8, pp. 449-462.
21. Imani, B., Eijkemans, M. J., Velde, E. R. te, Habbema, J. D. and Fauser, B. C. (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal of Clinical Endocrinology & Metabolism, 83, pp. 2361-2365.
22. Imani, B., Eijkemans, M. J., Velde, E. R. te, Habbema, J. D. and Fauser, B. C. (2002) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertility & Sterility, 77, pp. 91-97.
23. Kousta, E., White, D. M. and Franks, S. (1997) Modern use of clomiphene citrate in induction of ovulation. Human Reproduction Update, 3, pp. 359-365.
24. Legro, R. S., Barnhart, H. X., Schlaff, W. D., Carr, B. R., Diamond, M. P. and Carson, S. A. (2007) Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. New England Journal of Medicine, 356, pp. 551-566.
25. Lobo, R. A., Gysler, M., March, C. M., Goebelsmann, U. and Mishell Jr., D. R. (1982) Clinical nd laboratory predictors of clomiphene response. Fertility & Sterility, 37, pp. 168-174.
26. Macgregor, A. H., Johnson, J. E. and Bunde, C. A. (1968) Further clinical experience with clomiphene citrate. Fertility & Sterility, 19, pp. 616-622.
27. Messinis, I. E. and Milingos, S. D. (1998) Future use of clomiphene in ovarian stimulation. Clomiphene in the 21st century. Human Reproduction, 13, pp. 2362-2365.
28. Mitwally, M. F. and Casper, R. F. (2000) Aromatase inhibition: A novel method of ovulation induction in women with polycystic ovary syndrome. Reproductive Technologies, 10, pp. 244-247.
29. Mitwally, M. F. and Casper, R. F. (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertility & Sterility, 75, pp. 305-309.
30. Mitwally, M. F. and Casper, R. F. (2004) Aromatase inhibitors in ovulation induction. Seminars in Reproductive Medicine, 22, pp. 61-78.
31. Moll, E., Bossuyt, P. M. M., Korevaar, J. C., Lambalk, C. B. and van der Veen, F. (2006) Ovulation induction in women with newly diagnosed polycystic ovary syndrome. A randomized double-blind clinical trial comparing clomiphene citrate plus metformin with clomiphene citrate and placebo. British Medical Journal, 332, pp. 1485-1488.
32. Polson, D. W., Kiddy, D. S., Mason, H. D. and Franks, S. (1989) Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and nonresponders. Fertility & Sterility, 51, pp. 30-34.
33. Rostami-Hodjegan, A., Lennard, M. S., Tucker, G. T. and Ledger, W. L. (2004) Monitoring plasma concentrations to individualize treatment with clomiphene citrate. Fertility & Sterility, 81, pp. 1187-1193.
34. Schenker, J. G., Yarkoni, S. and Granat, M. (1981) Multiple pregnancies following induction of ovulation. Fertility & Sterility, 35, pp. 105-123.
35. Scialli, A. R. (1986) The reproductive toxicity of ovulation induction. Fertility & Sterility, 45, pp. 315-323.
36. Sohrabvand, F., Ansari, S. and Bagheri, M. (2006) Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene in clomiphene resistant infertile women with polycystic ovary disease. Human Reproduction, 21, pp. 1432-1435.
37. Tredway, D. R., Buraglio, M., Hemsey, G. and Denton, G. (2004) A phase I study of the pharmacokinetics, pharmacodynamics, and safety of single- and multiple-dose anastrozole in healthy, premenopausal female volunteers. Fertility & Sterility, 82, pp. 1587-1593.
38. Tulandi, T., Martin, J., Al-Fadhli, R., Hitkari, J., Kabli, N. and Forman, R. (2006) Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertility & Sterility, 85, pp. 1761-1765.
39. Wu, C. H. and Winkel, C. A. (1989) The effect of therapy initiation day on clomiphene citrate therapy. Fertility & Sterility, 52, pp. 564-568.
40. Wu, H. H., Wang, N. M., Cheng, M. L. and Hsieh, J. N. (2007) A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility. Gynecological Endocrinology, 23, pp. 76-81.